The synthesis of five new analogues of benzopsoralens, derived from xanthen-9-one and carbazole is described. The preparation of the hydroxylated precursors, their formylation and the formation of the pyranone ring, by the reaction between ortho-formylated heterocycles and diethyl malonate in EtOH, will be discussed. The inhibitory effect on the growth of human tumour cell lines (MCF-7, SF-268 and NCI-460) of the final products was evaluated and is discussed in terms of the 3D-geometry and electronic density distribution. The compounds showing significant biological activity in this study were those having angular structures.
1. Introduction.-Psoralens are natural products derived from coumarin. Some of their derivatives are photosensitising drugs and are used for treatment of various skin diseases (e.g. cutaneous malignant melanoma) [1] , blood decontamination, and some AIDS related infections [2] . In a previous publication, our research group prepared psoralen analogues (e.g. 1) based on dibenzofuran [3] and studied their properties. Some of them showed sensitization of singlet oxygen with high quantum efficiency [4] and good ability to inhibit the in vitro growth of three human tumour cell lines representing different tumour types, MCF-7 (breast cancer), NCI-H460 (non-small cell lung cancer) and SF-268 (CNS cancer) [5] .
In view of the antitumour properties referred above for compounds of type 1, it was decided to evaluate the effects on the biological properties of modifications on the furan ring. The first modification consisted on the replacement of the oxygen atom by NH giving 2 and 3, isosters of oxopyranodibenzofuran (1) . The replacement of the furan ring by 1,4-pyranone gave xanthone derivatives, 4, 5 and 6, close analogues of xanthonolignoids studied previously by members of our group [6] . The five tetracyclic compounds which were synthesized were tested for their growth inhibitory activity against three human tumor cell lines.
2.
Results and discussion.-2.1. Chemistry. In order to build the pyranone ring by the same method that was used before [3] , ortho-hydroxyaldehydes compounds, were needed as starting materials.
The hydroxylated xanthen-9-ones 7 were prepared by known procedures [7] and were then formylated, to give products 8, by different methods.
The first attempt to formylate the hydroxylated xanthones 7 used the Duff reaction [7, 8] . By this method, hydroxyaldehydes 8b, 8c, 8d, and 8a were obtained in 56, 32, 17, and 13% yields, respectively (Scheme 1). The Reimer-Tiemann formylation [9] gave compound 8a in an even lower yield (6%). In the 1 H-NMR spectra of all the hydroxyaldehydes 8, a low field signal was observed corresponding to the H-bonded OH, and the lowest signal of all (δ = 13.54 ppm)
corresponded to compound 8a.
INSERT SCHEME 1
The pyranone ring was built from ortho-formylhydroxyxanthen-9-ones 8b-8c, by reflux with diethyl malonate in EtOH in the presence of AcOH and pyridine [10] (Scheme 2) and compounds 4 and 5 were obtained in 50 and 55% yields, respectively. In the 1 H-NMR spectra, the signals of the hydroxyl and aldehyde groups were replaced by a low field singlet, corresponding to H-1 of the pyranone ring. It is interesting to point out that the low field singlet for compound 4 appears at δ 10.57 and for compound 5 at 9.21 ppm. As a consequence of the low yields of the formylation of hydroxyxanthenones 7a and 7d, the preparation of the corresponding oxopyrano-xanthenones, was not accomplished.
INSERT SCHEME 2
5
For the synthesis of pyranoxanthen-9-one 6, another approach was used. 3-Methoxyxanthen-9-one was reduced [11] to the 3-methoxyxanthene (77%, LiAlH 4 ) (Scheme 3).
Vilsmeier formylation [12] (POCl 3 and N-methylformanilide) gave the aldehyde 9a in 31% yield, which was demethylated quantitatively, using BBr 3 [13] , to give the aldehyde 9b (Scheme 3).
The usual method was applied for the construction of the pyranone ring, reacting 9b with diethyl malonate, and xanthene 10 was obtained in high yield (73%).
Oxidation of 10 by chromium (VI) oxide [7a] gave 6 in 83% yield (Scheme 3).
INSERT SCHEME 3
Aldehydes 11b and 11c were obtained from commercial 2-hydroxycarbazole. The
Reimer-Tiemann formylation gave 11b in 20% yield [14] (Scheme 4), whereas 11c was prepared in 32% by subsequent metalation and treatment with DMF [16] from the carbamate 11a, which was obtained in good yield (c.f. [15] ).
INSERT SCHEME 4
The ortho-formylhydroxycarbazoles 11b and 11c were then converted to the oxopyranocarbazoles 2 and 3, in 17 and 27% yield, respectively, following the usual method [10] .
The structures of the final products were confirmed by mass spectrometry, IR and NMR spectroscopy.
Biological activity -Effect of compounds on the growth of human tumour cell lines

6
The ability of oxopyranoxanthenones 4, 5 and 6 and the oxopyranocarbazoles 2 and 3 to inhibit the in vitro growth of MCF-7, NCI-H460 and SF-268 cell lines was evaluated and the results, given in concentrations that were able to cause 50% of cell growth inhibition (GI 50 ), are summarized in Table 1 .
Among the compounds tested the angular pyranocarbazole 2 was found to have the best inhibitory activity against all the three cell lines, while pyranocarbazole 3, a compound with a related structure but with a different orientation of the pyranone ring, was found to be ineffective as growth inhibitor even when tested at concentrations of 150 µM.
The pyranoxanthenone 4 exhibited only a growth inhibitory effect against MCF-7 cells being ineffective against SF-268 and NCI-H460 cell lines. This result is in agreement with that observed for xanthonolignoids [6, 17] where the equivalent angular xanthonolignoid revealed some selectivity to MCF-7 cells [6] . This different cell line response could reflect a possible tumour type-specific sensitivity of this compound for the breast cancer cell line. Compound 5 with the same functional groups, but a different orientation, showed a three fold decrease in its inhibitory activity against MCF-7 cell, but without the selectivity detected with compound 4.
Although the number of the compounds tested is limited, some structural features important to the growth inhibitory effect can be inferred. Angular compounds showed in general higher activity (c.f. compound 2 in the three cell lines and compound 4 on MCF-7). It has been previously observed that angular compound 1 [5] was active on these cell lines (Table 1) . All compounds possess close molecular volumes (Table 2) . However, as observed in a previous study [5] , the growth inhibitory activity presented by some of these compounds is due to the 3D-geometry and electronic density distribution.
INSERT
INSERT TABLE 2
A simple inspection of the MEP/TED figures and structure of these compounds, [5] . However, it is compound 2 that shows the greatest ability to inhibit the in vitro growth of MCF-7, NCI-H460 and SF-268 cell lines (Table 2) , which is comparable to that observed before for compound 1 [5] . The charge distribution over the atoms of these molecules is surprisingly similar (Figure 1 ).
INSERT FIG. 1
The oxopyranoxanthenones, 4 and 5, present similar conformation, but they show specific variations in the charge distribution at some critical points. It was observed that compound 5 had only a slight inhibitory effect, while 4 showed a moderate growth inhibitory effect only against the MCF-7 cell line. This reflects the strict dependence between tumour type-specific sensitivity and a combination of 3D-geometry and a specific charge distribution ( Figure 2 ).
INSERT FIG. 2 8
These two compounds display a negative charge density localized in the internal part of the molecule, due to a carbonyl group (compound 4), and an oxygen atom from the xanthenone ring (compound 5). The local electronic effect caused by the carbonyl group in 4 seems to be responsible for its specificity to MCF-7 cell line.
Despite this, the behaviour presented by compounds 4 and 5 suggests that a negative charge localized in this region is able to lower the tumour growth inhibitory activity. This is in agreement with the observations reported in a previous work, where the inhibitory activity of some benzopsoralens (including compound 1, [5] ) was studied. A fifth interaction point must be introduced in the previously proposed model, involving the internal part of the condensed ring system of the bioactive compound and the bioreceptor. This point must be of major importance in the association bioactive compound/ bioreceptor, inducing the tumour growth inhibitory activity if the electronic density is positive, as it is the case for compounds 1 and 2.
Conclusions
The synthesis of five new analogues of benzopsoralens, derived from xanthen-9-one and carbazole was described.
Some of the compounds synthesized (4, 5, and 2) showed an interesting growth inhibitory effect against the MCF-7, SF-268 and NCI-H460 cell lines. All the compounds showing some biological activity (4, 5 and 2) have angular structures revealing the importance of the global molecular topology as previously observed for xanthonolignoids.
Specific 3D-geometry and charge distribution are responsible for the biological activity displayed by some of these compounds. The behaviour presented by 9 compound 2, very similar to that presented by compound 1, and by compounds 4
and 5 suggests that a fifth interaction point must be included in the previously proposed model [5] , involving the internal part of the condensed ring of the bioactive compound and the bioreceptor(s). This seems to play a major role in the interaction between the bioactive compound and the bioreceptor(s).
Experimental Part
Chemistry
General: Light petroleum refers to solvent boiling in the range 40-60º. Column chromatography (CC) was performed on, silica gel 60 (70-230 mesh, Merck).
Melting points were determined on a Gallenkamp apparatus and are uncorrected.
UV spectra were recorded in EtOH on a SHIMADZU UV-2501 PC and data are (8)); 7.78 (ddd, J = 7.8, 7.5, 1.5, H-C(6)); 7.75 (d, J = 9.6, H-C(4) or H-C(3));
7.53 (br d, J = 7.8, H-C (5)); 7.48-7.40 (m, 2H, H-C(7), and H-C(3) or H-C (4)).
For other hydroxyxanthenones the reflux duration was variable and estimated by TLC (5 h, 2 h and 7 h, for 1, 3 and 4-hydroxyxanthen-9-one, resp.). It was necessary to use column chromatography or preparative chromatography to obtain 1-hydroxy-9-oxoxanthene-2-carbaldehyde and 4-hydroxy-9-oxoxanthene-3-carbaldehyde. All the aldehydes were obtained as yellow crystals.
3-Hydroxy-9-oxoxanthene-4-carbaldehyde (8c). Yellow crystals (32%). M.p.:
212-215º (EtOH) (lit. [18] : 223º (EtOH)). IR (Nujol): 1650 (strong, C=O), 1615, 1463, 1414, 1344, 1316, 1215, 1168, 1068, 819, 760, 735 1612, 1463, 1345, 1293, 1234, 1216, 1297, 1019, 982, 904, 829, 806, 759, 743, 689 . 
240.0423).
General method of formation of the pyranone ring: To a soln. of 2-hydroxy-9-oxoxanthene-1-carbaldehyde 8b (38 mg, 0.16 mmol) in EtOH (6 ml) diethyl malonate (35 mg, 0.22 mmol, previously dissolved in 1 ml EtOH), one drop of AcOH and one drop of piperidine were added and the mixture was refluxed for 3.5 h. A precipitate formed on cooling and was filtered off and washed with cold EtOH. 3,12-dioxopyran[3,2-a] 1562, 1466, 1327, 1249, 1227, 1207, 1119, 1035, 968, 900, 834, 799, 774, 725, 684 . (1) (5) (1)), 7.09-7.01 (m, H-C (5) and H-C(7)), 6.67 (dd, J = 8.3, 2.5, H-C(2)), 6.62 (d, J = 2.5, H-C(4)), 4.00 (s, CH 2 ), 3.81 (s, OMe). 1628, 1609, 1572, 1505, 1468, 1445, 1426, 1405, 1330, 1307, 1290, 1235, 1185, 1113, 1015, 963, 894, 830, 773, 753 . 1 H-NMR: 10.34 (s, CHO), 7.77 (s, H-C(1)), 7.25-7.18 (m, H-C(6) and H-C(8)), 7.11-7.03 (m, H-C (7) and H-C (5) (m, H-C (5) and H-C (7)), 6.64 (s, H-C (4)), 4.04 (s, CH 2 ).
Ethyl
3-Methoxyxanthene-2-carbaldehyde (9a).
Ethyl 2-oxopyran [3,2-b] 1615, 1564, 1456, 1303, 1295, 1275, 1233, 1195, 1136, 1033, 991, 907, 847, 797, 750, 731, 666 . 1 H-NMR: 8.49 (s, H-C (4)), 7.43 (s, H-C (5)), 7.30-7.20 and 7.15-7.08 (m, H-C (7), H-C(8), H-C(9) and H-C(10)), 7.03 (s, H-C (12) 
322.0841).
Ethyl 2,6-dioxopyran[3,2-b] xanthene-3-carboxylate (6). To a soln. of the pyranoxanthene 10 (32 mg, 0.10 mmol) in pyridine (5 ml) powdered chromium (VI) oxide (40 mg, 0.40 mmol) was added and the mixture was left stirring at room temperature for 2.5 h. The mixture became dark brown and a solid precipitated. The mixture was poured over HCl 2 M (30 ml) and was extracted with CHCl 3 (3x 30 ml) and EtOAc (4 x 30 ml). The extracts were combined, dried and the solvent was evaporated. The resulting solid was crystallized from a mixture of CHCl 3 and MeOH. The chromatographic control (TLC) was done using (4) or H-C (5) (12) 
Synthesis of the pyranocarbazoles
Reimer-Tiemann formylation. 2-Hydroxycarbazole (2 g, 11 mmol), was treated with CHCl 3 and NaOH and gave, after column chromatography (Et 2 O/petrol, 1:9), 2-hydroxycarbazole-1-carbaldehyde 11b as yellow crystals, (0.46 g, 20%). M.p.:
219-220º (decomposes above 200º) (lit. [12c]: 232º (EtOH)). IR (Nujol): 3405
(NH), 1633 (C=O), 1598, 1318, 1278, 1206, 1170, 1115, 1085, 1032, 938, 784, 775, 757, 743, 722 . The carbamate was used without further purification.
2-(N,N-Diethylcarbamoyl)-carbazole (11a).
Light brown oil (0.634 g, 92%), which was used without purification. IR (film): 3408, 3307 (NH), 2975, 2934, 1700 (strong, C=O), 1633, 1611, 1461, 1422, 1380, 1326, 1271, 1230, 1166, 1119, 1002, 971, 865, 748, 727, 666 . (0.634 g, 2.25 mmol) in dry THF (6 ml) was added. After 60 min. DMF (0.7 ml) was added, the mixture was left for 2 h while it reached room temperature and then it was left stirring for 48 h. During this period the solution changed from yellow to brown. A saturated soln. of ammonium chloride (75 ml) was added and the mixture was extracted with chloroform (3 x 20 ml (7)), 7.27 (ddd, J = 8.1, 7.2, 0.9, H-C (6)), 6.94 (s, H-C (1)).
iii) Formation of the pyranone ring
Ethyl 3-oxopyran [3,2-a] 1614 , 1345 , 1330 , 1257 , 1217 , 1193 , 1117 , 1089 , 1034 (br s, NH), 9.25 (br s, H- (1) (2)), 112.26 (C(10)), 108.27 (C (5) (11) (C(7)), 110.73 (C(11a)), 96.83 (C (5) 
Tumour cell growth assay:
The effects of compounds on the growth of tumour cell lines MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) and SF-268 (CNS cancer) were evaluated according to the procedure adopted by the National Cancer Institute (NCI, USA) for in vitro anticancer drug screening using the protein-binding dye sulforhodamine B (SRB) to assess growth inhibition [20, 21] . Cells were routinely maintained as adherent cell cultures in RPMI-1640 medium supplemented with 5% heat-inactivated fetal bovine serum, 2 mM glutamine and 50 µg/mL of gentamicin at 37º in an humidified atmosphere containing 5% CO 2 . The optimal plating density of each cell line, that ensure exponential growth throughout all the experimental period, was the same as originally published [20] and was respectively 7.5x10 corresponding to the concentration of compound that inhibits 50% of the net cell growth was determined as described [20] . Doxorubicin, used as a positive control, was tested in the same manner.
Theoretical calculations:
The structure of the isolated molecules was initially optimized using the semi-empirical method PM3 [22] . Subsequentely, these structures were refined using the Density Functional Theory (DFT) [23] . The B3LYP hybrid functional and 6-31G* basis sets was used.
In the DFT optimizations, the Berny gradient was used. The requested convergence limit on RMS density matrix was 1 x 10 -8 and the threshold values for the maximum force and the maximum displacement were 0.000450 and 0.001800 a.u. respectively.
The visualization of the structures was performed with GaussView 3 [24] . The molecular volumes were calculated using the facilities of Hyperchem 5.11 [25] . 
